VenoStent
VenoStent, Inc. is a clinical-stage medical device company developing SelfWrap, a bioabsorbable perivascular wrap designed to improve the usability and durability of arteriovenous fistulas for hemodialysis patients. This device aims to address the high failure rate of AV fistulas, improving patient outcomes and quality of life.
Funding Round: Series A
Funding Amount: $20M
Date: 27-Jun-2024
Investors: Norwest Venture Partners, Good Growth Capital, IAG Capital Partners
Markets: Medtech, Healthcare, Medical Device, Advanced Materials, Biotechnology, Life Science
HQ: Houston, Texas, United States
Founded: 2017
Website: https://www.venostent.com/
LinkedIn: https://www.linkedin.com/company/venostent
Twitter: https://twitter.com/venostent
Crunchbase: https://www.crunchbase.com/organization/venostent
Leave a Comment
Comments
No comments yet.